Skip to main content
Clinical Trials/JPRN-UMIN000048569
JPRN-UMIN000048569
Recruiting
N/A

A prospective observational study for the diagnosis of fatty deposits and fibrosis in non-alcoholic fatty liver disease with circulating natriuretic peptides - Diagnosis of non-alcoholic fatty liver disease with circulating natriuretic peptides

Sapporo Medical University0 sites500 target enrollmentSeptember 1, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
on-alcoholic fatty liver disease
Sponsor
Sapporo Medical University
Enrollment
500
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 1, 2022
End Date
March 31, 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Patients with a history diagnosed or treated with heart failure 2\. Patients with alcohol intake (ethanol conversion) of 30g/day for males and 20g/day for females 3\. Patients diagnosed with liver cirrhosis 4\. Patients who have a history of infection or who are treated with hepatitis B or hepatitis C 5\. Patients with intrahepatic malignant tumors such as hepatocellular carcinoma 6\. Patients with a diagnosis of any malignancy 7\. Patients under treatment with steroids, immunosuppressants, anticancer drugs, etc. 8\. Patients diagnosed with chronic inflammatory diseases, such as autoimmune hepatitis, inflammatory bowel disease 9\. Patients who do not consent to this study 10\. Patients who are judged to be inappropriate as research subjects by the research director

Outcomes

Primary Outcomes

Not specified

Similar Trials